CereCRIB implant: Completed enrollment for the Phase I equivalent trial

CytoTherapeutics Inc. (CTII), Providence, RI Product: CereCRIB implant containing bovine adrenal chromaffin cells that release catecholamines and enkephalins Indication: Severe, chronic pain Status: C...